Re. Benton et al., GRAPEFRUIT JUICE ALTERS TERFENADINE PHARMACOKINETICS RESULTING IN PROLONGATION OF REPOLARIZATION ON THE ELECTROCARDIOGRAM, Clinical pharmacology and therapeutics, 59(4), 1996, pp. 383-388
Objectives: To establish whether the pharmacokinetics and electrocardi
ographic pharmacodynamics of terfenadine are affected by concomitant a
dministration of grapefruit juice and to determine whether any effect
of grapefruit juice is dependent on the timing of administration in re
lation to the dose of terfenadine. Methods: Twelve healthy volunteers
were studied in a prospective randomized trial, The primary end points
were QT prolongation on the surface electrocardiogram and the pharmac
okinetic parameters: area under the concentration-time curve (AUC), ma
ximum concentration, and time to maximum concentration of terfenadine
and its acid metabolite terfenadine carboxylate. All subjects received
60 mg terfenadine twice a day with 240 ml water for 7 days, They were
then randomized to drink 240 ml of double-strength grapefruit juice s
imultaneously with terfenadine (simultaneous group) for an additional
7 days or to drink the same dose of grapefruit juice 2 hours after ter
fenadine for 7 days (delayed group), Twelve timed electrocardiograms a
nd plasma terfenadine and metabolite levels were measured on days 7 an
d 14, Results: None of the 12 subjects had quantifiable levels of terf
enadine when the drug was administered with water, All six subjects wh
o took terfenadine and drank grapefruit juice simultaneously had quant
i fiable terfenadine levels, Only two of six who drank grapefruit juic
e 2 hours after terfenadine had quantifiable levels, The AUC of the ac
id metabolite increased 55% (p < 0.05) in the simultaneous group and 2
2% (p = NS) in the delayed group, The mean QT interval increased from
420 to 434 msec (p < 0.05) in the simultaneous group and decreased fro
m 408 to 407 msec (p = NS) in the delayed group. Conclusions: Administ
ration of grapefruit juice concomitantly with terfenadine may lead to
an increase in systemic terfenadine bioavailability and result in incr
eases in QT interval, The clinical significance of an increase in QT i
nterval of this magnitude is unclear.